(Date:12/16/2009)... Peptone. HSP A has been found to be effectinve in ... ... 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high ... and yields. HSP-A has been found to be especially effective ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
(Date:12/15/2009)... 15 Repligen Corporation (Nasdaq: RGEN ... $731,000 in research funding to support the ongoing ... the Muscular Dystrophy Association (MDA). This grant ... testing and GMP manufacture of a drug candidate ... MDA not only provides important funding for Repligen,s ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18... Albert Liou, Corporate Vice President and General Manager, ... PRXL ), a leading global biopharmaceutical services provider, will ... Global Clinical Development Strategy" at the BioMedical Asia 2009 ... at the Suntec Singapore International Convention & Exhibition Centre ...
... all outstanding shares of Genentech for US$95.00 per ... operate as an independent center; South San Francisco ... operations; Genentech,s unique culture to be maintained-- Innovation ... approaches and sharing of IP, technologies, partnerships and ...
... Catilin, Inc.AMES, Iowa, March 11 Catilin, Inc., a ... Demonstration Fund award of $150,000 by the Iowa Department ... the upgrade of Catilin,s biodiesel pilot plant, from batch ... plant in the continuous mode is the final step ...
Other Biology Technology:PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 2PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 3PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 4Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 2Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 3Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 4Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 5Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 6Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 7Catilin Receives Renewable Energy Award for Pilot Plant 2(Date:12/15/2009)... horses may have been grazing the North American ... thought. After plucking ancient DNA from frozen soil ... cutting-edge techniques to uncover "genetic fossils" of both ... 7,600 and 10,500 calendar years. This new evidence ... now-extinct mammals endured longer in the continental interior, ...
(Date:12/15/2009)... of Spanish and American researchers found the fossil remains of ... they have published, for the first time, the results of ... of the young cetacean, possibly a baleen whale from the ... the partial fossil remains of a whale from the Lower ... formation, but it is the first time that the results ...
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Swine flu could wreak more havoc on US economy says UAB economist 58170 1Swine flu could wreak more havoc on US economy says UAB economist 58170 2Researchers identify new brain pathway for regulating weight and bone mass 10065 1Researchers identify new brain pathway for regulating weight and bone mass 10065 2Cambridge Healthtech Institute and Bio IT World Launch a New eNewsletter 3A Pharma Services News 58168 1Cambridge Healthtech Institute and Bio IT World Launch a New eNewsletter 3A Pharma Services News 58168 2Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11...
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
... monoclonal antibody raised against a ... Immunogen: TOPORS (NP_005793, ... partial recombinant protein with GST ... Number: NM_005802 ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Biology Products:Biology NavigationMedical Navigation